Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients

19 Aug 2020

Abstract excerpt

BACKGROUND: The clinical features of adult-onset atopic dermatitis (AD) are heterogeneous and the diagnosis can be a challenge. A new biologic drug (dupilumab) has been approved for moderate to severe AD in adult patients. The efficacy and safety have been demonstrated in clinical trials, but these studies do not reflect conditions in daily practice and do not consider the different clinical manifestations of AD....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asthma and respiratory diseases
Share to Dermatology and Skin Diseases
Share to Psoriasis: Treatment and Pathogenesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32824992
DOI: 10.3390/jcm9092684

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 PatientsPMID 32824992Read ↗

Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.Semantic proximity Read ↗

Clinical phenotypes of adult atopic dermatitis and related therapies.Semantic proximity Read ↗

Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy.Semantic proximity Read ↗

Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.Semantic proximity Read ↗

New pathogenic and therapeutic paradigms in atopic dermatitis.Semantic proximity Read ↗

The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment.Semantic proximity Read ↗

Adult-Onset Atopic Dermatitis: Presentations and Progress.Semantic proximity Read ↗

Effectiveness of dupilumab in pediatric patients with a nummular phenotype of atopic dermatitis.Semantic proximity Read ↗

Deciphering atopic dermatitis heterogeneity: a short review on the translational revolution from endotypes to immunotypes.Semantic proximity Read ↗

[The status and prospects of studies about atopic dermatitis].Semantic proximity Read ↗

Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.Semantic proximity Read ↗

Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) Registry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.